InVitae (NVTA) Reports Q4 Loss of $0.78, Beats on Revenues; Offers FY18 Revenue Outlook Below Consensus

Note: EPS may not be comparable

InVitae (NYSE: NVTA) reported Q4 EPS of ($0.78), versus ($0.60) reported last year. Revenue for the quarter came in at $25.4 million versus the consensus estimate of $24.58 million.

For the fourth quarter of 2017, Invitae reported a net loss of $40.5 million, or a $0.78 loss per share, compared to a net loss of $24.8 million in the fourth quarter of 2016, or a $0.69 loss per share.

2018 Guidance

For 2018, the company announced it anticipates accessioning at least 250,000 samples and generating at least $120 million in revenue for the combined organization.

GUIDANCE:

InVitae sees Q1 2018 revenue of $120 million, versus the consensus of $124.87 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c